New monitor tested in transplant patients to improve care
NCT ID NCT07148323
First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times
Summary
This study is testing a new monitoring platform called HemoSphere Alta in 100 adults having heart or liver transplant surgery. The goal is to collect data to help improve the device, not to treat a disease. Participants must be at least 18 years old and already scheduled for a pulmonary artery catheter during surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMODYNAMIC INSTABILITY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Rochester Medical Center
Rochester, New York, 14620, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Morning or afternoon surgery? study tests if body clock alters anesthesia safety
- Could a common vasodilator unclog microvessels in septic shock?
- Can ultrasound help doctors give the right amount of fluids in septic shock?
- Neck ultrasound may guide fluid delivery during surgery
- Fluid bolus study reveals how IV fluids impact heart and brain in low blood volume
- Pulse check: could a simple touch replace the blood pressure cuff in emergencies?